# Bioequivalence Study Doxycycline Tablets and Monodox Capsules Under Fasting Conditions

> **NCT00652795** · PHASE1 · COMPLETED · sponsor: **Par Pharmaceutical, Inc.** · enrollment: 36 (actual)

## Conditions studied

- To Determine Bioequivalence Under Fasting Conditions

## Interventions

- **DRUG:** Doxycycline Monohydrate
- **DRUG:** Monodox

## Key facts

- **NCT ID:** NCT00652795
- **Lead sponsor:** Par Pharmaceutical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2004-09
- **Final completion:** 2004-09
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2008-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00652795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00652795, "Bioequivalence Study Doxycycline Tablets and Monodox Capsules Under Fasting Conditions". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00652795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*